Insight A Conversation with WIT’s ITC Practice Chair: Examining 2024 Trends in Section 337 Investigations
Insights Home Insights Featured Content Blog Antitrust Disputes: Thoughts from Two Industry Experts on Google and More To understand antitrust disputes in today’s legal landscape, we asked two of our esteemed experts to offer insights on the trajectory of their industry as regulations continue to rapidly evolve. Case Study- Technology Case Study: Telecommunications Industry Expert Needed for International Regulatory Dispute A telecommunications provider sued a competitor for allegedly bypassing its international call fees through VoIP technology. The defendant countered with claims of regulatory and antitrust violations, leading them to engage with WIT for a telecommunications expert to address the complex economic and competitive issues at stake. Blog Perspectives on the Amendment to Rule 702 To better understand how the amendment is reshaping the way expert testimony is being handled, we contacted key stakeholders for their insights. From the perspectives of an attorney, expert liaison, and expert witness, these changes are prompting more thorough vetting and strategic planning in selecting experts for matters. Blog Key Takeaways from October’s Legal Industry Conferences In October, WIT attended three industry conferences that explored the rapidly shifting landscape of regulation, litigation, and corporate strategy. Here’s a breakdown of the most significant takeaways from each event. Event Centerforce’s IP Strategy Summit – NYC WIT Legal will sponsor Centerforce's IP Strategy Summit – NYC in New York on November 20th, 2024. Insights & News All Industries Automotive Financial Technology Gaming Healthcare Technology Pharmaceutical Wireless Communications Medical Devices All Trends 5G / 6G Banking Crisis COVID-19 Cryptocurrency Drug and Vaccine Development Election Law and Voting Rights Electric Vehicles FDA-Regulated Drugs and Devices Mobile Gaming Payment Systems Virtual Reality Wearable Devices All Insight Types Archive Blog Case Study Case Study- Life Sciences Case Study- Technology Event In the News Other Content Press Release Q&As Report Video Search October 23, 2024 — Blog Life Sciences Roundup: Top Insights from Q2 – Q3 Life sciences companies face mounting litigation over patents, products, and pricing practices. Successfully navigating these matters requires expertise from qualified experts and an expert agency focused on arising litigation trends. Check out our insights. August 16, 2024 — Q&As A Biotechnology Expert Assesses the Life Sciences Landscape We asked WIT biotechnology expert and accomplished academic, Dr. Brenda Wilson, to evaluate the industry with respect to ongoing trends, impactful innovations, and litigation challenges. June 18, 2024 — Report A National Study of Community Attitudes Toward Pharmaceutical Companies WIT commissioned the DOAR Research Center to conduct a national study of community attitudes toward pharmaceutical companies and several issues suspected of creating bias. Learn more about their findings. June 12, 2024 — Report Hatch-Waxman Spotlight: Senior Judge Richard Andrews Our latest Hatch-Waxman report provides a comprehensive analysis of Senior Judge Richard Andrews' activity at the United States District Court for the District of Delaware since his appointment in November 2011. Learn more about our findings. March 20, 2024 — Press Release WIT Legal Releases New Report on 2023 Activities and Trends in Hatch-Waxman Litigation The report examines Abbreviated New Drug Application (ANDA) cases and the Orange Book-listed products at issue. October 25, 2023 — Event ACI’s 28th Annual Conference on Drug & Medical Device Litigation WIT Legal will be sponsoring ACI's 28th Annual Conference on Drug & Medical Device Litigation on December 5-6 in NYC. October 2, 2023 — Blog Expert Perspective: What is Driving Growth and Litigation in the Biotechnology Space? The biotechnology market is headed towards transformational growth as the landscape shifts, resulting from impending patent cliffs, increased M&A activity, and ongoing innovation. WIT biotech expert Peter Lankau provides insights on what's to come in the industry for the remainder of this year and beyond. July 26, 2023 — Blog Big Pharma’s Balancing Act: Navigating Patent Thickets in the Age of Biosimilars Biosimilar patent cases are complex legal battles that require the support of various experts to bolster the nuanced arguments presented by pharmaceutical companies. May 24, 2023 — In the News Will the FTC’s Amgen Suit Ignite Future Pharmaceutical M&A Conflicts? With M&A activity in the life sciences sector heating up, the latest dispute in the space may affect the future of pharmaceutical acquisitions. How will the FTC's recent case against Amgen ignite future M&A conflicts, and where can experts assist in the litigation process? May 17, 2023 — Blog Retaining Experts for Three Top Trends in Life Sciences in 2023 What are three growing trends in life sciences with legal implications, their drivers, and the types of experts that would be advantageous to retain? Learn more. Load More Loading...
Blog Antitrust Disputes: Thoughts from Two Industry Experts on Google and More To understand antitrust disputes in today’s legal landscape, we asked two of our esteemed experts to offer insights on the trajectory of their industry as regulations continue to rapidly evolve.
Case Study- Technology Case Study: Telecommunications Industry Expert Needed for International Regulatory Dispute A telecommunications provider sued a competitor for allegedly bypassing its international call fees through VoIP technology. The defendant countered with claims of regulatory and antitrust violations, leading them to engage with WIT for a telecommunications expert to address the complex economic and competitive issues at stake.
Blog Perspectives on the Amendment to Rule 702 To better understand how the amendment is reshaping the way expert testimony is being handled, we contacted key stakeholders for their insights. From the perspectives of an attorney, expert liaison, and expert witness, these changes are prompting more thorough vetting and strategic planning in selecting experts for matters.
Blog Key Takeaways from October’s Legal Industry Conferences In October, WIT attended three industry conferences that explored the rapidly shifting landscape of regulation, litigation, and corporate strategy. Here’s a breakdown of the most significant takeaways from each event.
Event Centerforce’s IP Strategy Summit – NYC WIT Legal will sponsor Centerforce's IP Strategy Summit – NYC in New York on November 20th, 2024.
October 23, 2024 — Blog Life Sciences Roundup: Top Insights from Q2 – Q3 Life sciences companies face mounting litigation over patents, products, and pricing practices. Successfully navigating these matters requires expertise from qualified experts and an expert agency focused on arising litigation trends. Check out our insights.
August 16, 2024 — Q&As A Biotechnology Expert Assesses the Life Sciences Landscape We asked WIT biotechnology expert and accomplished academic, Dr. Brenda Wilson, to evaluate the industry with respect to ongoing trends, impactful innovations, and litigation challenges.
June 18, 2024 — Report A National Study of Community Attitudes Toward Pharmaceutical Companies WIT commissioned the DOAR Research Center to conduct a national study of community attitudes toward pharmaceutical companies and several issues suspected of creating bias. Learn more about their findings.
June 12, 2024 — Report Hatch-Waxman Spotlight: Senior Judge Richard Andrews Our latest Hatch-Waxman report provides a comprehensive analysis of Senior Judge Richard Andrews' activity at the United States District Court for the District of Delaware since his appointment in November 2011. Learn more about our findings.
March 20, 2024 — Press Release WIT Legal Releases New Report on 2023 Activities and Trends in Hatch-Waxman Litigation The report examines Abbreviated New Drug Application (ANDA) cases and the Orange Book-listed products at issue.
October 25, 2023 — Event ACI’s 28th Annual Conference on Drug & Medical Device Litigation WIT Legal will be sponsoring ACI's 28th Annual Conference on Drug & Medical Device Litigation on December 5-6 in NYC.
October 2, 2023 — Blog Expert Perspective: What is Driving Growth and Litigation in the Biotechnology Space? The biotechnology market is headed towards transformational growth as the landscape shifts, resulting from impending patent cliffs, increased M&A activity, and ongoing innovation. WIT biotech expert Peter Lankau provides insights on what's to come in the industry for the remainder of this year and beyond.
July 26, 2023 — Blog Big Pharma’s Balancing Act: Navigating Patent Thickets in the Age of Biosimilars Biosimilar patent cases are complex legal battles that require the support of various experts to bolster the nuanced arguments presented by pharmaceutical companies.
May 24, 2023 — In the News Will the FTC’s Amgen Suit Ignite Future Pharmaceutical M&A Conflicts? With M&A activity in the life sciences sector heating up, the latest dispute in the space may affect the future of pharmaceutical acquisitions. How will the FTC's recent case against Amgen ignite future M&A conflicts, and where can experts assist in the litigation process?
May 17, 2023 — Blog Retaining Experts for Three Top Trends in Life Sciences in 2023 What are three growing trends in life sciences with legal implications, their drivers, and the types of experts that would be advantageous to retain? Learn more.
